🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to investigate the safety and efficacy of Rotigotine add-on t...
Status
Completed
Location
402
Start Date
2012-10
Trial ID
NCT01723904
Treatments Being Tested
A conversion study of Mirapex (pramipexole) to Requip (ropinirole) controll...
Status
Completed
Location
University of Kansas Medical Center
Start Date
2006-01
Trial ID
NCT00275275
The purpose of this study is to assess the safety and feasibility of switch...
Status
Completed
Location
505
Start Date
2012-09
Trial ID
NCT01711866
Treatments Being Tested
The primary objective is to demonstrate safety and tolerability of switchin...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2014-08
Trial ID
NCT01976871
Treatments Being Tested
The purpose of this clinical trial is to investigate the effects of the non...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01007864
Treatments Being Tested
The purpose of this trial is to assess whether it is possible for subjects ...
Status
Completed
Location
Schwarz
Start Date
2004-12
Trial ID
NCT00242008
Treatments Being Tested
The primary objective of the study is to determine whether Butrans Transder...
Status
Withdrawn
Location
Massachusetts General Hospital
Start Date
2014-04
Trial ID
NCT02138357
Treatments Being Tested
The purpose of this study is to determine the equipotent dose of ropinirole...
Status
Completed
Location
Medical College of Georgia
Start Date
2006-05
Trial ID
NCT00344994
Treatments Being Tested
1. In order to observe the benefit, side effects, and patient preference of...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2011-09
Trial ID
NCT01515774
Treatments Being Tested
This study will evaluate the effectiveness of naltrexone in reducing ICD sy...
Status
Completed
Location
University of Pennsylvania
Start Date
2009-11
Trial ID
NCT01052831
Treatments Being Tested